Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules
Tanaji T. Talele
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 19, pp. 8712-8756
Closed Access | Times Cited: 792
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
Syed Sohail Ahmed, Wayne Volkmuth, José S. Duca, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 294
Closed Access | Times Cited: 228
Structural basis of ligand recognition at the human MT1 melatonin receptor
Benjamin Stauch, Linda C. Johansson, John D. McCorvy, et al.
Nature (2019) Vol. 569, Iss. 7755, pp. 284-288
Open Access | Times Cited: 168
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
New paradigms in GPCR drug discovery
Kenneth A. Jacobson
Biochemical Pharmacology (2015) Vol. 98, Iss. 4, pp. 541-555
Open Access | Times Cited: 163
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Structures of G protein-coupled receptors reveal new opportunities for drug discovery
Roger Cooke, Alastair Brown, Fiona H. Marshall, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 11, pp. 1355-1364
Closed Access | Times Cited: 123
Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor
Zhenlin Yang, Shuo Han, Max Keller, et al.
Nature (2018) Vol. 556, Iss. 7702, pp. 520-524
Open Access | Times Cited: 122
Current strategies for protein production and purification enabling membrane protein structural biology
Aditya Pandey, Kyungsoo Shin, Robin E. Patterson, et al.
Biochemistry and Cell Biology (2016) Vol. 94, Iss. 6, pp. 507-527
Open Access | Times Cited: 114
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists
Takashi Nagahara, Tsuyoshi Saitoh, Noriki Kutsumura, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 20, pp. 7931-7937
Closed Access | Times Cited: 109
High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist
Janosch Ehrenmann, Jendrik Schöppe, Christoph Klenk, et al.
Nature Structural & Molecular Biology (2018) Vol. 25, Iss. 12, pp. 1086-1092
Closed Access | Times Cited: 109
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Structural studies of G protein‐coupled receptors
Mengjie Lu, Beili Wu
IUBMB Life (2016) Vol. 68, Iss. 11, pp. 894-903
Open Access | Times Cited: 104
The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR–Ligand Interactions
Alexander Heifetz, Ewa I. Chudyk, Laura Gleave, et al.
Journal of Chemical Information and Modeling (2015) Vol. 56, Iss. 1, pp. 159-172
Open Access | Times Cited: 103
Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations
Yoonji Lee, Shaherin Basith, Sun Choi
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 1, pp. 1-46
Open Access | Times Cited: 101
X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog
Wataru Shihoya, Tomohiro Nishizawa, Keitaro Yamashita, et al.
Nature Structural & Molecular Biology (2017) Vol. 24, Iss. 9, pp. 758-764
Closed Access | Times Cited: 95
G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
Juan Zhao, Yulin Deng, Zhaotan Jiang, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 89
In Vitro and In Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist
Carsten T. Beuckmann, Michiyuki Suzuki, Takashi Ueno, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 2, pp. 287-295
Open Access | Times Cited: 89
Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists
Jendrik Schöppe, Janosch Ehrenmann, Christoph Klenk, et al.
Nature Communications (2018) Vol. 10, Iss. 1
Open Access | Times Cited: 89
Ligand binding at the protein–lipid interface: strategic considerations for drug design
Jian Payandeh, Matthew Volgraf
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 710-722
Closed Access | Times Cited: 88
Crystal structure of the human oxytocin receptor
Yann Waltenspühl, Jendrik Schöppe, Janosch Ehrenmann, et al.
Science Advances (2020) Vol. 6, Iss. 29
Open Access | Times Cited: 86
Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode
Yuki Shiimura, Shoichiro Horita, Akie Hamamoto, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy Perturbation
Francesca Deflorian, Laura Pérez‐Benito, Eelke B. Lenselink, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 11, pp. 5563-5579
Closed Access | Times Cited: 75
Page 1 - Next Page

Scroll to top